Konsenserfahrung von International Uveitis Study Group, Intraocular Inflammation Society und Foster Ocular Inflammation Society zur Uveitis in der Zeit der COVID-19-Infektion

Manfred Zierhut; Marc D.Smet de; Vishali Gupta; Carlos Pavesio; Quan Dong Nguyen; Soon-Phaik Chee; Rupesh Agarwal

doi:10.1055/a-1201-3277

Klinische Monatsblätter für Augenheilkunde, Inhaltsverzeichnis

Klin Monbl Augenheilkd 2020; 237(09): 1124-1128
DOI: 10.1055/a-1201-3277

Statement

Konsenserfahrung von International Uveitis Study Group, Intraocular Inflammation Society und Foster Ocular Inflammation Society zur Uveitis in der Zeit der COVID-19-Infektion^[*]

Evolving Consensus of International Uveitis Study Group, Intraocular Inflammation Society, and Foster Ocular Inflammation Society with Uveitis in the Time of COVID-19 Infection

Manfred Zierhut

¹Universitäts-Augenklinik, Universitätsklinikum Tübingen

,

Marc D.Smet de

²Retina and Inflammation Unit, Microinvasive Ocular Surgery Clinic, Lausanne, Schweiz

,

Vishali Gupta

³Ophthalmology, Advance Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, Indien

,

Carlos Pavesio

⁴Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust, London, Vereinigtes Königreich von Großbritannien und Nordirland

,

Quan Dong Nguyen

⁵Byers Eye Institute, Spencer Center for Vision Research, Stanford, USA

,

Soon-Phaik Chee

⁶Ophthalmology, Singapore National Eye Center, Singapur

,

Rupesh Agarwal

⁷Ophthalmology, Singapore Eye Research Institute, Singapur

› Institutsangaben

Abstract

Zusammenfassung

Dieses Dokument fasst die Erfahrungen der International Uveitis Study Group (IUSG), der Intraocular Inflammation Society (IOIS) und der Foster Ocular Inflammation Society (FOIS) zusammen und kann als Leitfaden für die Behandlung von Uveitispatienten im Zeitalter der COVID-19-Pandemie dienen.

Abstract

This document summarizes the experience of the International Uveitis Study Group (IUSG), the Intraocular Inflammation Society (IOIS) and the Foster Ocular Inflammation Society (FOIS) and can aid as a guide for the treatment of uveitis patients in the era of COVID-19 pandemic.

Schlüsselwörter

Uveitis - Konsensus - COVID-19 - Immunsuppression

Key words

uveitis - consensus - COVID-19 - immune suppression

Volltext

Referenzen

Literatur
1 Yang J, Zheng Y, Gou X. et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis 2020;
2 Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 2020; 395: 473-475
3 Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. J Heart Lung Transplant 2020; 39: 405-407
4 Kampf G, Todt D, Pfaender S. et al. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect 2020; 104: 246-251
5 Li W, Moore MJ, Vasilieva N. et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003; 426: 450-454
6 Patel AB, Verma A. COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence?. JAMA 2020;
7 Ferguson NM, Laydon D, Nedjati-Gilani G. Imperial College COVID-19 Response Team. Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. London: Imperial College; 16 March 2020. Im Internet (Stand: 16.07.2020): https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-NPI-modelling-16-03-2020.pdf
8 DʼAntiga L. Coronaviruses and immunosuppressed patients. The facts during the third epidemic. Liver Transpl 2020; 26: 832-834 doi:10.1002/lt.25756
9 Norsa L, Indriolo A, Sansotta N. et al. Uneventful course in IBD patients during SARS-CoV-2 outbreak in northern Italy. Gastroenterology 2020;
10 Bhoori S, Rossi RE, Citterio D. et al. COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy. Lancet Gastroenterol Hepatol 2020; 5: 532-533 doi:10.1016/S2468-1253(20)30116-3
11 Zhou Y, Fu B, Zheng X. et al. Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID 19 patients. Natl Sci Rev 2020;
12 Mehta P, McAuley DF, Brown M. et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020; 395: 1033-1034 doi:10.1016/S0140-6736(20)30628-0
13 Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Imm Infl 2020;
14 Wu P, Duan F, Luo C. et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol 2020; 138: 575-578 doi:10.1001/jamaophthalmol.2020.1291
15 Liu Z, Sun CB. Conjunctiva is not a preferred gateway of entry for SARS-CoV-2 to infect respiratory tract. J Med Virol 2020;
16 Sun CB, Wang YY, Liu GH. et al. Role of the eye in transmitting human coronavirus: what we know and what we do not know. Front Public Health 2020; 8: 155 doi:10.3389/fpubh.2020.00155
17 Navel V, Chiambaretta F, Dutheil F. Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2. Am J Ophthalmol Case Rep 2020; 19: 100735 doi:10.1016/j.ajoc.2020.100735
18 Marinho PM, Marcos AAA, Romano AC. et al. Retinal findings in patients with COVID-19. Lancet 2020; 395: 1610 doi:10.1016/S0140-6736(20)31014-X
19 Casagrande M, Fitzek A, Püschel K. et al. Detection of SARS-CoV-2 in human retinal biopsies of deceased COVID-19 patients. Ocul Immunol Inflamm 2020;
20 Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med 2020; 58: 1131-1134 doi:10.1515/cclm-2020-0198

Weitere Quellen
1 International Agency for the Prevention of Blindness. COVID-19 & Eye Health. Im Internet (Stand: 16.07.2020): https://www.iapb.org/news/covid-19-resources-here-is-what-we-know/
2 American Academy of Ophthalmology. Important coronavirus updates for ophthalmologists. Im Internet (Stand: 16.07.2020): https://www.aao.org/headline/alert-important-coronavirus-context
3 American Academy of Ophthalmology. Coronavirus and Eye Care. Im Internet (Stand: 16.07.2020): https://www.aao.org/coronavirus
4 World Health Organization. Rolling updates on coronavirus disease (COVID-19). Im Internet (Stand: 16.07.2020): https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen
5 Uveitis National Clinical Study Group. Uveitis Clinical Study Group COVID-19 Info Hub. Im Internet (Stand: 16.07.2020): https://www.uveitisstudygroup.org/?id=15
6 Casey Eye Institute. Best practice for prevention of droplet or contact transmission of infectious agents in ophthalmology clinics. Im Internet (Stand: 16.07.2020): https://www.ohsu.edu/sites/default/files/2020-03/CEI Clinic Protocol for Suspect or Confirmed COVID-19 Patients 2020-03-12.pdf
7 University Health Network (UHN). UHN Droplet Precautions PPE Instructional Video. Im Internet (Stand: 16.07.2020): https://www.youtube.com/watch?v=Ww0Rf079MZ4
8 MS Research Australia. An update from MS Research Australia on COVID-19. Im Internet (Stand: 16.07.2020): https://msra.org.au/news/ceo-message-covid-19/

Konsenserfahrung von International Uveitis Study Group, Intraocular Inflammation Society und Foster Ocular Inflammation Society zur Uveitis in der Zeit der COVID-19-Infektion[*]

Konsenserfahrung von International Uveitis Study Group, Intraocular Inflammation Society und Foster Ocular Inflammation Society zur Uveitis in der Zeit der COVID-19-Infektion^[*]